EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Gut Microbiome in Early-Onset Colorectal Cancer: Distinct Signatures, Targeted Prevention and Therapeutic Strategies

Sara Lauricella iD, Francesco Brucchi, Roberto Cirocchi iD, Diletta Cassini iD, Marco Vitellaro iD

Journal of Personalized Medicine · 12.11.2025 · 15 (11) · 552

DOI: 10.3390/jpm15110552 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 12.11.2025. Verfasst von Sara Lauricella und 4 weiteren Autor:innen. Beteiligte Einrichtung: Colorectal Surgery Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, 20133 Milan, Italy. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The incidence of early-onset colorectal cancer (EOCRC) is rising worldwide, although its biological and clinical features remain incompletely understood. Emerging evidence implicates gut microbial dysbiosis as a key driver of EOCRC pathogenesis, acting through complex interactions with host genetics, mucosal immunity, and early-life exposures. This review synthesizes current evidence on EOCRC-specific microbial signatures, delineates host–microbiome interactions, and evaluates how these insights may inform precision prevention, early detection, and therapeutic strategies.

Methods

A systematic literature search was conducted in PubMed, Scopus, and Web of Science up to August 2025, using combinations of “early-onset colorectal cancer,” “gut microbiome,” “dysbiosis,” and “host–microbiome interactions.” Both clinical and preclinical studies were included. Extracted data encompassed microbial composition, mechanistic insights, host-related factors, and microbiome-targeted interventions. Evidence was synthesized narratively to highlight consistent patterns, methodological limitations, and translational implications.

Results

EOCRC is consistently associated with enrichment of pro-inflammatory and genotoxic taxa (e.g., Fusobacterium nucleatum, colibactin-producing Escherichia coli, enterotoxigenic Bacteroides fragilis) and depletion of short-chain fatty acid–producing commensals. Multi-omics analyses reveal distinct host–microbiome signatures influenced by germline predisposition, mucosal immunity, sex, and early-life exposures. However, substantial methodological heterogeneity persists. Collectively, these data point to candidate microbial biomarkers for early detection and support the rationale for microbiome-targeted preventive and adjunctive therapeutic approaches.

Conclusions

EOCRC harbors unique microbial and host–environmental features that distinguish it from late-onset disease. Integrating host determinants with microbiome signatures provides a framework for precision prevention and tailored therapeutic strategies. Future priorities include harmonizing methodologies, validating microbial biomarkers in asymptomatic young adults, and rigorously testing microbiome-targeted interventions in clinical trials.

Schlagwörter

Stichwörter der Autor:innen

dysbiosisearly-onset colorectal cancergut microbiomemicrobial signaturesmicrobiota

Autor:innen und Institutionen

  • Colorectal Surgery Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, 20133 Milan, Italy.
  • Hereditary Digestive Tract Tumors Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Giacomo Venezian 1, 20133 Milan, Italy.
  • General Surgery Residency Program, University of Milan, 20122 Milan, Italy.
  • Digestive and Emergency Surgery Unit, Santa Maria Hospital Trust, 05100 Terni, Italy.
  • Unit of General Surgery, Sesto San Giovanni Hospital, ASST Nord Milano, 20099 Sesto San Giovanni, Italy.

ORCID-Profile: Sara Lauricella, Roberto Cirocchi, Diletta Cassini, Marco Vitellaro

Zitieren

APA

Lauricella, S., Brucchi, F., Cirocchi, R., Cassini, D., & Vitellaro, M. (2025). The Gut Microbiome in Early-Onset Colorectal Cancer: Distinct Signatures, Targeted Prevention and Therapeutic Strategies. Journal of Personalized Medicine, 15(11), 552. https://doi.org/10.3390/jpm15110552

Vancouver

Lauricella S, Brucchi F, Cirocchi R, Cassini D, Vitellaro M. The Gut Microbiome in Early-Onset Colorectal Cancer: Distinct Signatures, Targeted Prevention and Therapeutic Strategies. Journal of Personalized Medicine. 2025;15(11):552. doi:10.3390/jpm15110552

BibTeX
@article{Lauricella2025,
  author = {Lauricella, Sara and Brucchi, Francesco and Cirocchi, Roberto and Cassini, Diletta and Vitellaro, Marco},
  title = {The Gut Microbiome in Early-Onset Colorectal Cancer: Distinct Signatures, Targeted Prevention and Therapeutic Strategies},
  journal = {Journal of Personalized Medicine},
  year = {2025},
  volume = {15},
  number = {11},
  pages = {552},
  doi = {10.3390/jpm15110552}
}
Kostenlos starten →